Christina Herder

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Christina Herder's trades of Elicera Therapeutics AB's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-12 2025-03-11
B Purchase
84,896
58.46
SEK2,825,162 		84,896 58.46 SEK2,825,162
2024-03-09 2024-03-08
B Purchase
60,986
451.12
SEK1,722,549 		60,986 451.12 SEK1,722,549
2023-01-17 2023-01-16
SE Idogen AB (IDOGEN)
B Purchase
93,463
363.52
SEK386,567 		93,463 363.52 SEK386,567
2022-02-13 2022-02-10
SE Idogen AB (IDOGEN)
B Purchase
16,500
3.06
SEK50,490 		16,500 3.06 SEK50,490
2021-02-10 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
5,000
7.00
SEK35,000 		5,000 7.00 SEK35,000
2021-02-04 2021-02-03
SE Medivir AB (MVIR-B)
B Purchase
5,000
7.00
SEK35,000 		5,000 7.00 SEK35,000
2020-03-19 2020-03-16
SE Idogen AB (IDOGEN)
B Purchase
92,000
0.60
SEK55,200 		92,000 0.60 SEK55,200
2018-12-07 2018-12-05
SE Idogen AB (IDOGEN)
B Purchase
31,429
1.75
SEK55,001 		31,429 1.75 SEK55,001
2018-02-21 2018-02-20
SE Medivir AB (MVIR-B)
B Purchase
5,000
39.95
SEK199,750 		5,000 39.95 SEK199,750
2017-06-21 2017-06-21
SE Idogen AB (IDOGEN)
B Purchase
1,250
42.00
SEK52,500 		1,250 42.00 SEK52,500